利福昔明预防和治疗肝性脑病的研究进展  

Rifaximin for prevention and treatment of hepatic encephalopathy

作　　者：叶江锋 琚坚[1] 

机构地区：[1]昆明医科大学第二附属医院特需病房科,云南省昆明市650101

出　　处：《世界华人消化杂志》2015年第7期1090-1096,共7页World Chinese Journal of Digestology

摘　　要：肝性脑病(hepatic encephalopathy,HE)是肝脏功能衰竭或门体分流引起的严重中枢神经系统神经精神综合症,严重影响着人们的身心健康.其发病机制目前尚不明确,但是氨中毒学说占主要地位,那么围绕着降氨的治疗是治疗HE的重要方法之一.本文旨在讨论利福昔明预防和治疗HE疗效的进展.Hepatic encephalopathy（HE） is a serious neuropsychiatric syndrome of the central nervous system caused by liver failure or portosystemic shunt,seriously affecting patients＇ physical and mental well being.Although the pathogenesis of HE is still unclear at present,ammonia poisoning is believed to play a dominant role.Thus,reduction of ammonia is an important treatment for HE.This paper discusses the role of rifaximin in the prevention and treatment of HE.

关 键 词：肝性脑病 利福昔明 预防 治疗 

分 类 号：R575.3[医药卫生—消化系统]